dsm-firmenich, a leading innovator in health, nutrition, and beauty, announced that it has secured market access for its 3-fucosyllactose (3-FL) human milk oligosaccharide (HMO) ingredient in the European Union (EU). The European Commission’s approval of 3-FL for use as a novel food ingredient in the EU is a result of a Novel Food application by Glycom A/S*. This breakthrough represents a major step towards enhancing market access for a wider portfolio of high-quality HMO products for use in the … [Read more...] about dsm-firmenich secures 3-fucosyllactose market access in the European Union